Info
13F
Schedule 13D
Ownership

Baker Bros. Advisors Lp - Significant Ownership

Signature - Title: /s/ Scott L. Lessing - Scott L. Lessing/ President, Baker Bros. Advisors (GP) LLC, its general partner
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Baker Bros. Advisors Lp.

Significant Ownership of Baker Bros. Advisors Lp

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
KALA	KALA BIO, Inc.	Common Stock, $0.001 par value per share	19.7%	$5.11M		1.2M		Baker Bros. Advisors LP	Dec 29, 2024
DBVT	DBV Technologies S.A.	Ordinary shares, nominal value 0.10 euro per share	17.1%	$200M		23.5M		Baker Bros. Advisors LP	Mar 27, 2025
SERA	Sera Prognostics, Inc.	Class A Common Stock, $0.0001 par value per share	16.1%	$18.4M		5.5M		Baker Bros. Advisors LP	Feb 12, 2025
REPL	Replimune Group, Inc.	Common Stock, $0.001 par value per share	14.3%	$100M		11M		Baker Bros. Advisors LP	Mar 7, 2025
CELC	Celcuity Inc.	Common Stock, par value $0.001 per share	11.3%	$47M	$17.4M	4.26M	+59%	Baker Bros. Advisors LP	Mar 31, 2025
NGNE	Neurogene Inc.	Common Stock, par value $0.000001 per share	9.96%	$22.9M		1.49M		Julian C. Baker	Mar 31, 2025
RYTM	Rhythm Pharmaceuticals, Inc.	Common Stock, par value $0.001 per share	8.9%	$361M		5.6M		Baker Bros. Advisors LP	Mar 31, 2025
IMTX	Immatics N.V.	Ordinary Shares, nominal value (euro)0.01 per share	6%	$35.4M		7.28M		Baker Bros. Advisors LP	Dec 31, 2024
CADL	Candel Therapeutics, Inc.	Common Stock, par value $0.01 per share	4.99%	$11.9M	-$2.55M	2.46M	-17.7%	Baker Bros. Advisors LP	Mar 31, 2025
BMEA	Biomea Fusion, Inc.	Common Stock, par value $0.0001 per share	4%	$3.19M		1.45M		Baker Bros. Advisors LP	Dec 31, 2024

Showing 1 to 10 of 10 entries

Schedules 13D/G Reported by Baker Bros. Advisors Lp:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.